For the millions who suffer from chronic sinus issues, life can feel like a constant battle against pressure, pain, and ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

Young adult men with chronic rhinosinusitis with nasal polyps were shown to be at greater risk of nasal polyp recurrence after endoscopic sinus surgery than elderly men and adult women of all ages. An ...

HOUSTON -- Treatment with omalizumab (Xolair) was associated with improved endoscopic, clinical, and patient-reported outcomes in two parallel phase III studies in patients with steroid-refractory ...

This new study, which followed patients up to 6 months after functional endoscopic sinus surgery, evaluated results using objective and subjective measures. “Nasal polyps are associated with ...

Antrochoanal polyps (ACPs) are benign, solitary lesions that originate from the mucosa of the maxillary sinus and extend into the nasal cavity towards the choana. They can present with unilateral ...

Please provide your email address to receive an email when new articles are posted on . A combined set of clinical and biological variables predicted polyp recurrence and severity among patients who ...

The presence of Charcot-Leyden crystals in nasal tissues may be used to predict the recurrence of eosinophilic chronic rhinosinusitis with nasal polyps, according to a letter published in Clinical and ...

WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

GSK's phase 3 trials ANCHOR-1 and ANCHOR-2 met co-primary endpoints for treating CRSwNP with depemokimab. Adverse event rates were similar between depemokimab and placebo in the trials. Ready to turn ...